Xiangfeng Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiangfeng Zhao has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Xun Zhu
Department of Immunology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China
5 shared publications - Bai-Rong Du
Department of Immunology, Norman Bethune College of Medicine, Jilin University, Changchun 130021, China
3 shared publications - Dong-Mei Yan
Department of Immunology, Norman Bethune College of Medicine, Jilin University, Changchun 130021, China
3 shared publications - Xiao Han
Department of Immunology, Norman Bethune College of Medicine, Jilin University, Changchun 130021, China
3 shared publications Bairong Du
Department of Immunology, Norman Bethune College of Medicine, Jilin University, Changchun 130021, China
2 shared publications- Hiroshi Matsuura
Shiga University of Medical Science
2 shared publications
Latest Publications
- Open Access
- 1 September 2012
- Published by Elsevier in Molecules and Cells
- Vol. 34 (3) , 263-270
A Novel Accessory Molecule Trim59 Involved in Cytotoxicity of BCG-Activated Macrophages
- 1 September 2012
- Published by Elsevier in Molecules and Cells
- Vol. 34 (3) , 263-270
Open AccessA Novel Accessory Molecule Trim59 Involved in Cytotoxicity of BCG-Activated Macrophages
- Open Access
Xiao Han, et al., GHGKHKNK Octapeptide (P-5m) Inhibits Metastasis of HCCLM3 Cell Lines via Regulation of MMP-2 Expression in in Vitro and in Vivo Studies. Molecules, 2012, 17, 1357-1372
The authors wish to make the following correction to this paper [1]: the correct name of the fourth author is Hiroshi Matsuura.
Open AccessXiao Han, et al., GHGKHKNK Octapeptide (P-5m) Inhibits Metastasis of HCCLM3 Cell Lines via Regulation of MMP-2 Expression in in Vitro and in Vivo Studies. Molecules, 2012, 17, 1357-1372
The authors wish to make the following correction to this paper [1]: the correct name of the fourth author is Hiroshi Matsuura.
- Open Access
GHGKHKNK Octapeptide (P-5m) Inhibits Metastasis of HCCLM3 Cell Lines via Regulation of MMP-2 Expression in in Vitro and in Vivo Studies
P-5m, an octapeptide derived from domain 5 of HKa, was initially found to inhibit the invasion and migration of melanoma cells. The high metastatic potential of melanoma cells was prevented by the HGK motif in the P-5m peptide in vitro and in an experimental lung metastasis model, suggesting that P-5m may play an important role in the regulation of tumor metastasis. The aim of this study was to measure the effect of P-5m on tumor metastasis of human hepatocarcinoma cell line (HCCLM3) in vitro and in vivo in a nude mouse model of hepatocellular carcinoma (HCC), and detect the mechanisms involved in P-5m-induced anti-metastasis. By gelatin zymography, matrix metallo-proteinases 2 (MMP-2) activity in HCCLM3 was dramatically diminished by P-5m peptide. In addition, the migration and metastasis of HCCLM3 cells was also inhibited by the peptide in vitro. In an orthotopic model of HCC in nude mice, P-5m treatment effectively reduced the lung metastasis as well as the expression of MMP-2 in the tumor tissues. Overall, these observations indicate an important role for P-5m peptide in HCC invasion and metastasis, at least partially through modulation MMP-2 expression. These data suggests that P-5m may have therapeutic potential in metastatic human hepatocarcinoma.
Open AccessGHGKHKNK Octapeptide (P-5m) Inhibits Metastasis of HCCLM3 Cell Lines via Regulation of MMP-2 Expression in in Vitro and in Vivo Studies
P-5m, an octapeptide derived from domain 5 of HKa, was initially found to inhibit the invasion and migration of melanoma cells. The high metastatic potential of melanoma cells was prevented by the HGK motif in the P-5m peptide in vitro and in an experimental lung metastasis model, suggesting that P-5m may play an important role in the regulation of tumor metastasis. The aim of this study was to measure the effect of P-5m on tumor metastasis of human hepatocarcinoma cell line (HCCLM3) in vitro and in vivo in a nude mouse model of hepatocellular carcinoma (HCC), and detect the mechanisms involved in P-5m-induced anti-metastasis. By gelatin zymography, matrix metallo-proteinases 2 (MMP-2) activity in HCCLM3 was dramatically diminished by P-5m peptide. In addition, the migration and metastasis of HCCLM3 cells was also inhibited by the peptide in vitro. In an orthotopic model of HCC in nude mice, P-5m treatment effectively reduced the lung metastasis as well as the expression of MMP-2 in the tumor tissues. Overall, these observations indicate an important role for P-5m peptide in HCC invasion and metastasis, at least partially through modulation MMP-2 expression. These data suggests that P-5m may have therapeutic potential in metastatic human hepatocarcinoma.
- Open Access
- 14 May 2011
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 10 (1) , 75
Prostaglandin E2 binding peptide screened by phage displaying: a new therapeutic strategy in rheumatoid arthritis
Objective: To investigate the therapeutic potential and mechanism of action of the mimotope of PGE2 receptor EP4 (PBP, named by our team) screened by phage displaying technique in the treatment of adjuvant-induced arthritis (AA). Methods: Freund's complete adjuvant-induced arthritis was induced in Wistar rats. At the first clinical sign of disease, mice were given with daily injections of PBP or saline for 21 days. Disease progression was monitored by measurement of paw swelling. Inflammation and joint destruction were assessed histologically. The IL-1β and TNF-α were studied by ELISA in the ankle steeps of arthritis model. The degree of proliferation and apoptosis of synoviocytes of RA patients were assessed by CCK-8 kit and Annexin⊠-FITC/PI respectively. Results: PBP-treated animals displayed significantly less cartilage and bone destruction than model controls. Tumor necrosis factor α and IL-1β expression were reduced after PBP treatment. The proliferation and apoptosis of synoviocytes of RA patients were influenced by PBP. Conclusions: The data support the view that PBP is a potential therapy for RA that may help to diminish both joint inflammation and destruction. And the activities of PBP are related with the effect on synoviocytes directly.
- 14 May 2011
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 10 (1) , 75
Open AccessProstaglandin E2 binding peptide screened by phage displaying: a new therapeutic strategy in rheumatoid arthritis
Objective: To investigate the therapeutic potential and mechanism of action of the mimotope of PGE2 receptor EP4 (PBP, named by our team) screened by phage displaying technique in the treatment of adjuvant-induced arthritis (AA). Methods: Freund's complete adjuvant-induced arthritis was induced in Wistar rats. At the first clinical sign of disease, mice were given with daily injections of PBP or saline for 21 days. Disease progression was monitored by measurement of paw swelling. Inflammation and joint destruction were assessed histologically. The IL-1β and TNF-α were studied by ELISA in the ankle steeps of arthritis model. The degree of proliferation and apoptosis of synoviocytes of RA patients were assessed by CCK-8 kit and Annexin⊠-FITC/PI respectively. Results: PBP-treated animals displayed significantly less cartilage and bone destruction than model controls. Tumor necrosis factor α and IL-1β expression were reduced after PBP treatment. The proliferation and apoptosis of synoviocytes of RA patients were influenced by PBP. Conclusions: The data support the view that PBP is a potential therapy for RA that may help to diminish both joint inflammation and destruction. And the activities of PBP are related with the effect on synoviocytes directly.
- 31 March 2011
- Published by Elsevier in Comparative Immunology, Microbiology and Infectious Diseases
- Vol. 34 (2) , 123-128
Phylogenetic analysis and prokaryotic expression of NMAAP1 derived from BCG-activated murine macrophages
- 31 March 2011
- Published by Elsevier in Comparative Immunology, Microbiology and Infectious Diseases
- Vol. 34 (2) , 123-128
Phylogenetic analysis and prokaryotic expression of NMAAP1 derived from BCG-activated murine macrophages